Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
Cell. 2013 Mar 28;153(1):126-38. doi: 10.1016/j.cell.2013.03.018.
Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs are highly somatically mutated and generated by a fraction of HIV-1-infected individuals several years after infection. Antibodies typically accumulate mutations in the complementarity determining region (CDR) loops, which usually contact the antigen. The CDR loops are scaffolded by canonical framework regions (FWRs) that are both resistant to and less tolerant of mutations. Here, we report that in contrast to most antibodies, including those with limited HIV-1 neutralizing activity, most bNAbs require somatic mutations in their FWRs. Structural and functional analyses reveal that somatic mutations in FWR residues enhance breadth and potency by providing increased flexibility and/or direct antigen contact. Thus, in bNAbs, FWRs play an essential role beyond scaffolding the CDR loops and their unusual contribution to potency and breadth should be considered in HIV-1 vaccine design.
广谱中和抗体(bNAbs)可预防 HIV-1 感染,因此对 HIV-1 疫苗设计具有重要意义。值得注意的是,bNAbs 高度体细胞突变,并且在感染后几年内由一小部分 HIV-1 感染者产生。抗体通常在互补决定区(CDR)环中积累突变,这些突变通常与抗原接触。CDR 环由规范的框架区(FWR)支架支撑,这些区域既具有抗突变性又对突变的容忍度较低。在这里,我们报告与大多数抗体(包括那些具有有限 HIV-1 中和活性的抗体)相反,大多数 bNAbs 需要其 FWR 中的体细胞突变。结构和功能分析表明,FWR 残基中的体细胞突变通过提供更大的灵活性和/或直接抗原接触来提高广度和效力。因此,在 bNAbs 中,FWR 除了支撑 CDR 环外还发挥着重要作用,其对效力和广度的特殊贡献应在 HIV-1 疫苗设计中加以考虑。